Mitochondrial ferritin in the substantia nigra in restless legs syndrome

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 11, 2009, Pages 1193-1199

  Snyder, Amanda M ^a   Wang, Xinsheng ^a   Patton, Stephanie M ^a   Arosio, Paolo ^b   Levi, Sonia ^c   Earley, Christopher J ^d   Allen, Richard P ^d   Connor, James R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Ferritin; Iron; Mitochondrion; Neuron; Restless leg syndrome

Indexed keywords

CYTOCHROME C OXIDASE; FERRITIN; IRON; NEUROMELANIN;

AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRION; NERVE CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PUTAMEN; QUANTITATIVE ANALYSIS; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA; TISSUE HOMOGENATE;

AGED; AGED, 80 AND OVER; CYTOSOL; FEMALE; FERRITINS; HUMANS; IRON; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NEURONS; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA;

EID: 70449413420     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181bdc44f     Document Type: Article

References (44)

1. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: The REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-46
2. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: The MEMO study. Memory and morbidity in Augsburg elderly. Neurology 2000;54:1064-68
3. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19
4. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005;58: 630-34
5. Allen RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-65
6. Godau J, Schweitzer KJ, Liepelt I, et al. Substantia nigra hypoechoge-nicity: Definition and findings in restless legs syndrome. Mov Disord 2006;22:187-92
7. Earley CJ, Allen RP, Beard JL, et al. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000;62:623-28
8. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-9
9. Mizuno S, Mihara T, Miyaoka T, et al. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005;14:43-47
10. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004;62:1563-67
11. Eisenstein RS. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000;20:627-62
12. Lin E, Graziano JH, Freyer GA. Regulation of the 75-kDa subunit of mitochondrial complex I by iron. J Biol Chem 2001;276:27685-92
13. Melefors O. Translational regulation in vivo of the Drosophila melanogaster mRNA encoding succinate dehydrogenase iron protein via iron responsive elements. Biochem Biophys Res Commun 1996;221: 437-41
14. Napier I, Ponka P, Richardson DR. Iron trafficking in the mitochondrion: Novel pathways revealed by disease. Blood 2005;105:1867-74
15. Paradkar PN, Zumbrennen KB, Paw BH, et al. Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol Cell Biol 2009;29:1007-16
16. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443:787-95
17. Levi S, Corsi B, Bosisio M, et al. A human mitochondrial ferritin encoded by an intronless gene. J Biol Chem 2001;276:24437-40
18. Drysdale J, Arosio P, Invernizzi R, et al. Mitochondrial ferritin: A new player in iron metabolism. Blood Cells Mol Dis 2002;29:376-83
19. Levi S, Arosio P. Mitochondrial ferritin. Internat J Biochem Cell Bio 2004;36:1887-89
20. Campanella A, Isaya G, O'Neill HA, et al. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum Mol Genet 2004;13:2279-88
21. Campanella A, Rovelli E, Santambrogio P, et al. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: Hypothesis for a protective role in Friedreich ataxia. Hum Mol Genet 2009;18:1-11
22. Corsi B, Cozzi A, Arosio P, et al. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 2002;277:22430-37
23. Elleder M, Borovansky J. Autofluorescence of melanins induced by ultraviolet radiation and near ultraviolet light. A histochemical and biochemical study. Histochem J 2001;33:273-81
24. Cavanna F, Ruggeri G, Iacobello C, et al. Development of a monoclonal antibody against human heart ferritin and its application in an im-munoradiometric assay. Clin Chim Acta 1983;134:347-56
25. Gutsaeva DR, Carraway MS, Suliman HB, et al. Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. J Neurosci 2008;28: 2015-24
26. Hausmann A, Samans B, Lill R, et al. Cellular and mitochondrial remodeling upon defects in iron-sulfur protein biogenesis. J Biol Chem 2008;283:8318-30
27. Chou YF, Yu CC, Huang RF. Changes in mitochondrial DNA deletion, content, and biogenesis in folate-deficient tissues of young rats depend on mitochondrial folate and oxidative DNA injuries. J Nutr 2007;137: 2036-42
28. Gutsaeva DR, Suliman HB, Carraway MS, et al. Oxygen-induced mitochondrial biogenesis in the rat hippocampus. Neuroscience 2006; 137:493-504
29. Mattingly KA, Ivanova MM, Riggs KA, et al. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol Endocrinol 2008;22:609-22
30. Rangwala SM, Li X, Lindsley L, et al. Estrogen-related receptor alpha is essential for the expression of antioxidant protection genes and mito-chondrial function. Biochem Biophys Res Commun 2007;357:231-36
31. Patton SM, Ponnuru P, Connor JR. Upregulation of HIF-1a and nNOS in Patients With RLS. Society for Neuroscience Meeting. Washington, DC: Washington Convention Center; 2008
32. Yin W, Signore AP, Iwai M, et al. Rapidly increased neuronal mito-chondrial biogenesis after hypoxic-ischemic brain injury. Stroke 2008; 39:3057-63
33. Winkelmann J, Lichtner P, Schormair B, et al. Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome. Mov Disord 2008;23:350-58
34. Clemens S, Rye D, Hochman S. Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006; 67:125-30
35. Qu S, Le W, Zhang X, et al. Locomotion is increased in a11-lesioned mice with iron deprivation: A possible animal model for restless legs syndrome. J Neuropathol Exp Neurol 2007;66:383-88
36. Earley CJ, Allen RP, Connor JR, et al. The dopaminergic neurons of the A11 system in RLS autopsy brains appear normal. Sleep Med March 21, 2009. [Epub ahead of print]
37. Liang CL, Wang TT, Luby-Phelps K, et al. Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease. Exp Neurol 2007;203:370-80
38. Chung CY, Seo H, Sonntag KC, et al. Cell typeYspecific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet 2005;14:1709-25
39. McCormack AL, Atienza JG, Langston JW, et al. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cells populations to paraquat-induced degeneration. Neuroscience 2006; 141:929-37
40. Thiruchelvam M, Brockel BJ, Richfield EK, et al. Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: Environmental risk factors for Parkinson's disease? Brain Res 2000;873:225-34
41. Thiruchelvam M, McCormack A, Richfield EK, et al. Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur J Neurosci 2003;18:589-600
42. Thiruchelvam M, Richfield EK, Baggs RB, et al. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: Implications for Parkinson's disease. J Neurosci 2000;20:9207-14
43. Uversky VN. Neurotoxicant-induced animal models of Parkinson's disease: Understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 2004;318:225-41
44. Snyder AM, Connor JR. Iron, the substantia nigra and related neurological disorders. Biochim Biophys Acta 2009;1790:606-14